Amexdrug Financials
| AXRX Stock | USD 0 0.00 0.00% |
Amexdrug |
Understanding current and past Amexdrug Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amexdrug's financial statements are interrelated, with each one affecting the others. For example, an increase in Amexdrug's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Amexdrug's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amexdrug. Check Amexdrug's Beneish M Score to see the likelihood of Amexdrug's management manipulating its earnings.
Amexdrug Stock Summary
Amexdrug competes with Balchem, Sonida Senior, National Vision, Cytek Biosciences, and Akanda Corp. Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. Amexdrug Corporation was founded in 1963 and is based in Commerce, California. AMEXDRUG CORPORATION operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. It employs 9 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 7251 Condor Street, |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.amexdrug.com |
| Phone | 323 725 3100 |
| Currency | USD - US Dollar |
Amexdrug Key Financial Ratios
Amexdrug's financial ratios allow both analysts and investors to convert raw data from Amexdrug's financial statements into concise, actionable information that can be used to evaluate the performance of Amexdrug over time and compare it to other companies across industries.| Return On Equity | 0.29 | |||
| Return On Asset | 0.11 | |||
| Beta | -0.72 | |||
| Z Score | 14.2 |
Amexdrug Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amexdrug's current stock value. Our valuation model uses many indicators to compare Amexdrug value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amexdrug competition to find correlations between indicators driving Amexdrug's intrinsic value. More Info.Amexdrug is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.39 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Amexdrug is roughly 2.56 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amexdrug by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amexdrug's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Amexdrug Systematic Risk
Amexdrug's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Amexdrug volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Amexdrug correlated with the market. If Beta is less than 0 Amexdrug generally moves in the opposite direction as compared to the market. If Amexdrug Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amexdrug is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amexdrug is generally in the same direction as the market. If Beta > 1 Amexdrug moves generally in the same direction as, but more than the movement of the benchmark.
Additional Tools for Amexdrug Pink Sheet Analysis
When running Amexdrug's price analysis, check to measure Amexdrug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amexdrug is operating at the current time. Most of Amexdrug's value examination focuses on studying past and present price action to predict the probability of Amexdrug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amexdrug's price. Additionally, you may evaluate how the addition of Amexdrug to your portfolios can decrease your overall portfolio volatility.